Volume | 489,925 |
|
|||||
News | - | ||||||
Day High | 13.70 | Low High |
|||||
Day Low | 12.83 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
13.35 | 12.83 | 13.70 | 13.64 | 13.17 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,151 | 489,925 | $ 13.41 | $ 6,572,084 | - | 8.20 - 18.24 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:36:02 | 40 | $ 13.64 | USD |
iTeos Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
488.9M | 35.84M | - | 12.6M | -112.64M | -3.14 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
iTeos Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 11.12 | 13.70 | 11.04 | 12.21 | 340,288 | 2.52 | 22.66% |
1 Month | 11.00 | 13.70 | 10.20 | 11.59 | 266,127 | 2.64 | 24.00% |
3 Months | 11.25 | 13.70 | 9.70 | 10.92 | 270,549 | 2.39 | 21.24% |
6 Months | 11.51 | 13.70 | 8.20 | 10.21 | 376,026 | 2.13 | 18.51% |
1 Year | 13.65 | 18.24 | 8.20 | 11.86 | 358,028 | -0.01 | -0.07% |
3 Years | 34.35 | 52.43 | 8.20 | 21.81 | 363,288 | -20.71 | -60.29% |
5 Years | 19.70 | 52.43 | 8.20 | 22.83 | 333,563 | -6.06 | -30.76% |
iTeos Therapeutics Description
ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |